Dublin, Oct. 26, 2018 (GLOBE NEWSWIRE) -- The "Global Depression Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering.

Global Depression Market and Competitive Landscape - 2018, provides comprehensive insights into Depression pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Depression market size and drug sales. This research also provides insights into Depression epidemiology and late stage pipeline.

The research is classified into following sections - Depression overview with definitions, symptoms, etiology, diagnosis, treatment options; Depression pipeline insights covering late stage clinical trials pipeline; Depression prevalence trends by countries; Depression market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries - US, Germany, France, Italy, Spain, UK, Japan.

Research Scope:

• Depression pipeline: Find out the drugs in clinical trials for Depression by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Depression epidemiology: Find out the prevalence of Depression by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
• Depression products: Identify key products marketed and prescribed for Depression by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
• Depression market size: Find out the market size for Depression drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
• Depression drug sales: Find out the sales of Depression drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
• Depression drugs sales forecast: Sales forecast for Depression drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
• Depression market share analysis: Find out the market shares of Depression drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

• Evaluate commercial market opportunities for Depression drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Depression market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Depression market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies
  

For more information about this report visit https://www.researchandmarkets.com/research/nf9flc/global_depression?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Mental Disorders Drugs 

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.